BioRestorative Historical Financial Ratios

BRTX Stock

USD 1.97 0.06 2.96%

BioRestorative Therapies is presently reporting on over 98 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 0.69 or Days Sales Outstanding of 45.66 will help investors to properly organize and evaluate BioRestorative Therapies financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRestorative Therapies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.

About BioRestorative Financial Ratios Analysis

BioRestorative TherapiesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate BioRestorative Therapies investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on BioRestorative financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across BioRestorative Therapies history.

BioRestorative Therapies Financial Ratios Chart

At this time, BioRestorative Therapies' PTB Ratio is fairly stable compared to the past year. Days Sales Outstanding is likely to rise to 45.66 in 2025, whereas Price To Sales Ratio is likely to drop 54.99 in 2025.

Book Value Per Share Free Cash Flow Yield Invested Capital Operating Cash Flow Per Share Long Term Debt To Capitalization Cash Flow To Debt Ratio

Add Fundamental

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Invested Capital

Invested capital represents the total cash investment that shareholders and debt holders have contributed to BioRestorative Therapies. There are two different methods for calculating BioRestorative Therapies invested capital: operating approach and financing approach. Understanding BioRestorative Therapies invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.

Operating Cash Flow Per Share

A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.

Most ratios from BioRestorative Therapies' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into BioRestorative Therapies current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRestorative Therapies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.At this time, BioRestorative Therapies' PTB Ratio is fairly stable compared to the past year. Days Sales Outstanding is likely to rise to 45.66 in 2025, whereas Price To Sales Ratio is likely to drop 54.99 in 2025.

	2024	2025 (projected)
Payables Turnover	1.48	1.55
Days Of Inventory On Hand	0.001496	0.001421

Payables Turnover Days Of Inventory On Hand

BioRestorative Therapies fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		-0.01	-0.98	-0.7	-0.11	-0.53	0.01	0.02	-0.01	1.0	-0.49	0.22	-0.74	-0.59	0.98	-0.4	0.74	0.3	0.81	-0.1	0.27	-0.02	-0.1	0.21	0.08	0.03
Ptb Ratio	-0.01		-0.02	0.17	-0.21	0.17	-0.35	-0.21	1.0	-0.02	0.21	0.09	-0.04	0.24	0.01	0.02	0.01	0.02	-0.03	0.83	-0.54	0.3	0.84	-0.16	0.29	-0.83
Days Sales Outstanding	-0.98	-0.02		0.62	0.01	0.41	0.0	0.06	-0.02	-0.99	0.37	-0.09	0.6	0.49	-1.0	0.3	-0.6	-0.11	-0.82	0.09	-0.19	-0.06	0.1	-0.18	-0.05	0.02
Book Value Per Share	-0.7	0.17	0.62		0.39	0.95	-0.09	-0.4	0.17	-0.67	0.94	-0.01	0.73	0.97	-0.62	0.53	-0.75	-0.52	-0.7	0.36	-0.41	0.38	0.29	-0.09	-0.35	0.0
Free Cash Flow Yield	-0.11	-0.21	0.01	0.39		0.57	0.22	0.17	-0.21	-0.07	0.49	-0.03	0.43	0.41	-0.01	0.14	-0.43	-0.52	-0.34	-0.41	-0.19	-0.18	-0.42	0.09	-0.37	-0.01
Operating Cash Flow Per Share	-0.53	0.17	0.41	0.95	0.57		-0.09	-0.44	0.17	-0.49	0.99	-0.03	0.73	0.98	-0.41	0.54	-0.75	-0.65	-0.57	0.29	-0.42	0.43	0.21	-0.11	-0.41	-0.02
Average Payables	0.01	-0.35	0.0	-0.09	0.22	-0.09		-0.13	-0.35	0.03	-0.07	-0.09	0.2	-0.14	0.02	-0.31	-0.17	-0.23	0.23	-0.46	0.45	-0.01	-0.5	0.48	0.11	0.1
Capex To Depreciation	0.02	-0.21	0.06	-0.4	0.17	-0.44	-0.13		-0.21	-0.02	-0.56	0.05	-0.33	-0.52	-0.07	-0.3	0.33	0.46	-0.25	-0.46	-0.07	-0.94	-0.32	-0.11	0.06	-0.1
Pb Ratio	-0.01	1.0	-0.02	0.17	-0.21	0.17	-0.35	-0.21		-0.02	0.21	0.09	-0.04	0.24	0.01	0.02	0.01	0.02	-0.03	0.83	-0.54	0.3	0.84	-0.16	0.29	-0.83
Ev To Sales	1.0	-0.02	-0.99	-0.67	-0.07	-0.49	0.03	-0.02	-0.02		-0.45	0.17	-0.69	-0.56	0.99	-0.38	0.69	0.23	0.82	-0.11	0.24	0.01	-0.11	0.21	0.1	0.03
Free Cash Flow Per Share	-0.49	0.21	0.37	0.94	0.49	0.99	-0.07	-0.56	0.21	-0.45		-0.03	0.72	0.99	-0.37	0.53	-0.74	-0.67	-0.48	0.36	-0.4	0.55	0.26	-0.08	-0.37	-0.02
Roic	0.22	0.09	-0.09	-0.01	-0.03	-0.03	-0.09	0.05	0.09	0.17	-0.03		-0.57	-0.04	0.09	-0.33	0.57	0.65	-0.05	0.21	0.25	-0.17	0.24	-0.02	-0.13	0.22
Inventory Turnover	-0.74	-0.04	0.6	0.73	0.43	0.73	0.2	-0.33	-0.04	-0.69	0.72	-0.57		0.73	-0.6	0.51	-1.0	-0.86	-0.5	-0.02	-0.28	0.34	-0.09	0.0	-0.17	-0.08
Net Income Per Share	-0.59	0.24	0.49	0.97	0.41	0.98	-0.14	-0.52	0.24	-0.56	0.99	-0.04	0.73		-0.49	0.55	-0.76	-0.61	-0.58	0.4	-0.45	0.54	0.31	-0.11	-0.34	-0.03
Days Of Inventory On Hand	0.98	0.01	-1.0	-0.62	-0.01	-0.41	0.02	-0.07	0.01	0.99	-0.37	0.09	-0.6	-0.49		-0.3	0.6	0.11	0.82	-0.1	0.2	0.07	-0.11	0.18	0.05	-0.01
Payables Turnover	-0.4	0.02	0.3	0.53	0.14	0.54	-0.31	-0.3	0.02	-0.38	0.53	-0.33	0.51	0.55	-0.3		-0.53	-0.45	-0.46	0.25	-0.04	0.39	0.21	-0.3	-0.5	0.16
Average Inventory	0.74	0.01	-0.6	-0.75	-0.43	-0.75	-0.17	0.33	0.01	0.69	-0.74	0.57	-1.0	-0.76	0.6	-0.53		0.86	0.52	-0.01	0.34	-0.36	0.06	0.0	0.15	0.1
Capex To Revenue	0.3	0.02	-0.11	-0.52	-0.52	-0.65	-0.23	0.46	0.02	0.23	-0.67	0.65	-0.86	-0.61	0.11	-0.45	0.86		0.1	0.07	0.26	-0.48	0.17	-0.06	0.16	0.12
Cash Per Share	0.81	-0.03	-0.82	-0.7	-0.34	-0.57	0.23	-0.25	-0.03	0.82	-0.48	-0.05	-0.5	-0.58	0.82	-0.46	0.52	0.1		-0.15	0.34	0.2	-0.19	0.1	0.21	0.0
Pocfratio	-0.1	0.83	0.09	0.36	-0.41	0.29	-0.46	-0.46	0.83	-0.11	0.36	0.21	-0.02	0.4	-0.1	0.25	-0.01	0.07	-0.15		-0.39	0.5	0.99	-0.07	0.18	-0.41
Interest Coverage	0.27	-0.54	-0.19	-0.41	-0.19	-0.42	0.45	-0.07	-0.54	0.24	-0.4	0.25	-0.28	-0.45	0.2	-0.04	0.34	0.26	0.34	-0.39		-0.1	-0.4	0.2	-0.29	0.53
Capex To Operating Cash Flow	-0.02	0.3	-0.06	0.38	-0.18	0.43	-0.01	-0.94	0.3	0.01	0.55	-0.17	0.34	0.54	0.07	0.39	-0.36	-0.48	0.2	0.5	-0.1		0.36	0.06	-0.02	0.0
Pfcf Ratio	-0.1	0.84	0.1	0.29	-0.42	0.21	-0.5	-0.32	0.84	-0.11	0.26	0.24	-0.09	0.31	-0.11	0.21	0.06	0.17	-0.19	0.99	-0.4	0.36		-0.09	0.21	-0.45
Days Payables Outstanding	0.21	-0.16	-0.18	-0.09	0.09	-0.11	0.48	-0.11	-0.16	0.21	-0.08	-0.02	0.0	-0.11	0.18	-0.3	0.0	-0.06	0.1	-0.07	0.2	0.06	-0.09		0.21	0.06
Income Quality	0.08	0.29	-0.05	-0.35	-0.37	-0.41	0.11	0.06	0.29	0.1	-0.37	-0.13	-0.17	-0.34	0.05	-0.5	0.15	0.16	0.21	0.18	-0.29	-0.02	0.21	0.21		-0.35
Roe	0.03	-0.83	0.02	0.0	-0.01	-0.02	0.1	-0.1	-0.83	0.03	-0.02	0.22	-0.08	-0.03	-0.01	0.16	0.1	0.12	0.0	-0.41	0.53	0.0	-0.45	0.06	-0.35

Click cells to compare fundamentals

BioRestorative Therapies Account Relationship Matchups

BioRestorative Therapies fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	141.48	112.06	83.05	50.33	57.88	54.99
Ptb Ratio	(8.18)	0.24	0.63	0.73	0.66	0.69
Days Sales Outstanding	80.58	39.67	48.75	48.32	43.48	45.66
Book Value Per Share	(3.37)	18.18	4.38	2.37	2.13	2.24
Free Cash Flow Yield	(0.18)	(0.65)	(0.63)	(0.9)	(0.81)	(0.85)
Operating Cash Flow Per Share	(4.98)	(2.8)	(1.62)	(1.52)	(1.37)	(1.44)
Stock Based Compensation To Revenue	8.98	502.37	105.28	53.38	61.39	58.32
Pb Ratio	(8.18)	0.24	0.63	0.73	0.66	0.69
Ev To Sales	163.91	(330.46)	71.57	45.38	52.19	49.58
Free Cash Flow Per Share	(4.98)	(2.83)	(1.74)	(1.57)	(1.41)	(1.48)
Roic	(0.83)	(0.79)	(1.14)	(1.5)	(1.72)	(1.64)
Net Income Per Share	(31.05)	(25.21)	(4.98)	(2.47)	(2.22)	(2.33)
Sales General And Administrative To Revenue	24.99	556.79	130.05	76.57	88.06	83.65
Research And Ddevelopement To Revenue	11.39	15.85	29.33	27.67	31.82	30.23
Cash Per Share	7.76	17.7	4.08	2.62	3.02	2.87
Pocfratio	(5.55)	(1.55)	(1.69)	(1.14)	(1.03)	(1.08)
Interest Coverage	(1.64)	(1.68)	(14.49)	(1.6K)	(1.9K)	(1.8K)
Pfcf Ratio	(5.55)	(1.53)	(1.58)	(1.11)	(1.0)	(1.05)
Roe	1.4	9.2	(1.39)	(1.14)	(1.04)	(1.2)
Ev To Operating Cash Flow	(1.14)	(6.43)	4.57	(1.46)	(0.93)	(0.97)
Pe Ratio	(0.89)	(0.17)	(0.55)	(0.7)	(0.63)	(0.67)
Return On Tangible Assets	(3.33)	(1.37)	(1.15)	(0.88)	(0.79)	(0.83)
Ev To Free Cash Flow	(6.43)	4.52	(1.36)	(1.0)	(0.9)	(0.95)
Earnings Yield	(1.12)	(5.81)	(1.81)	(1.42)	(1.28)	(1.34)
Intangibles To Total Assets	0.15	0.0263	0.0489	0.0566	0.0651	0.0618
Net Debt To E B I T D A	(0.18)	0.78	0.0729	0.048	0.0432	0.0453
Current Ratio	3.05	59.01	34.36	4.37	3.93	5.78
Tangible Book Value Per Share	(5.06)	17.69	4.15	2.2	1.98	2.08
Receivables Turnover	4.53	9.2	7.49	7.55	6.8	3.69
Graham Number	48.54	101.55	22.14	11.48	13.2	12.54

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
V	Visa Class A
C	Citigroup

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

BioRestorative Historical Financial Ratios

About BioRestorative Financial Ratios Analysis

BioRestorative Therapies Financial Ratios Chart

Book Value Per Share

Free Cash Flow Yield

Invested Capital

Operating Cash Flow Per Share

BioRestorative Therapies fundamentals Correlations

BioRestorative Therapies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BioRestorative Therapies fundamentals Accounts

Also Currently Popular

Additional Tools for BioRestorative Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 0.99	Operating Cash Flow Per Share
Days Of Inventory On Hand	+ 0.99	Ev To Sales
Net Income Per Share	+ 0.99	Free Cash Flow Per Share
Pfcf Ratio	+ 0.99	Pocfratio

Average Inventory	- 1.0	Inventory Turnover
Days Of Inventory On Hand	- 1.0	Days Sales Outstanding
Ev To Sales	- 0.99	Days Sales Outstanding
Days Sales Outstanding	- 0.98	Price To Sales Ratio
Capex To Operating Cash Flow	- 0.94	Capex To Depreciation
Capex To Revenue	- 0.86	Inventory Turnover